Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | EVP, Operations & Supply Chain | June 25, 2018 | June 26, 2018 |
| US Foods Holding Corp.USFD · Entity 3215 | EVP & Chief Supply Chain Off. | June 03, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date June 25, 2018 · Filed June 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,808 |
Reported balance
After 2018-06-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-06-25 · Grant · Acquired 42,808 · Balance 42,808 F1: Restricted stock grant which vests one-third per year over three years. |
| Common StockSEC Table I · non-derivative | Direct | 62,785 |
Reported balance
After 2018-06-25 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-06-25 · Grant · Acquired 19,977 · Balance 62,785 F2: Restricted stock with three year vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock grant which vests one-third per year over three years.
F2: Restricted stock with three year vesting date.
US Foods Holding Corp.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,395 |
Reported balance
After 2019-06-03 transaction · row 1
1 source rowRow 1 · 2019-06-03 · Grant · Acquired 45,395 · Balance 45,395 F1: The restricted stock units were granted on June 3, 2019 and vest in three equal annual installments beginning on June 3, 2020. Each restricted stock unit represents a right to receive one share of the Issuer's common stock. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.88 · Expires 2029-06-03 | Direct | 35,311 |
Reported balance
After 2019-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-06-03 · Grant · Acquired 35,311 · Balance 35,311 F2: The stock option was granted on June 3, 2019 and vests and becomes exercisable in three equal annual installments beginning on June 3, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units were granted on June 3, 2019 and vest in three equal annual installments beginning on June 3, 2020. Each restricted stock unit represents a right to receive one share of the Issuer's common stock.
F2: The stock option was granted on June 3, 2019 and vests and becomes exercisable in three equal annual installments beginning on June 3, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 5, 2019 21:58 UTC | US Foods Holding Corp. USFD · Entity 3215 | GrantEmployee Stock Option (right to buy) · Derivative | 35,311 | $0.00 Strike: $34.88 | $0.00 |
DisclosureSEC source: 0001665918-19-000140 · wf-form4_155977190930211.xml · derivative · entry 2 Connolly Timothy P · CIK 0001383126 · EVP & Chief Supply Chain Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,311 Underlying: Common Stock · 35,311 shares Expires 2029-06-03 F2 · derivative.exercise_date: The stock option was granted on June 3, 2019 and vests and becomes exercisable in three equal annual installments beginning on June 3, 2020. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 21:58 UTC | US Foods Holding Corp. USFD · Entity 3215 | GrantCommon Stock | 45,395 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001665918-19-000140 · wf-form4_155977190930211.xml · nonDerivative · entry 1 Connolly Timothy P · CIK 0001383126 · EVP & Chief Supply Chain Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,395 F1 · price: The restricted stock units were granted on June 3, 2019 and vest in three equal annual installments beginning on June 3, 2020. Each restricted stock unit represents a right to receive one share of the Issuer's common stock. Read SEC document |
| June 25, 2018 Filed Jun 26, 2018 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 19,977 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000101 · edgar.xml · nonDerivative · entry 2 Connolly Timothy P · CIK 0001383126 · EVP, Operations & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,785 F2 · security: Restricted stock with three year vesting date. Read SEC document |
| June 25, 2018 Filed Jun 26, 2018 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 42,808 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000101 · edgar.xml · nonDerivative · entry 1 Connolly Timothy P · CIK 0001383126 · EVP, Operations & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,808 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.